Literature DB >> 26944930

Modification of Antigen Impacts on Memory Quality after Adenovirus Vaccination.

Julia M Colston1, Beatrice Bolinger2, Matthew G Cottingham3, Sarah Gilbert3, Paul Klenerman1.   

Abstract

The establishment of robust T cell memory is critical for the development of novel vaccines for infections and cancers. Classical memory generated by CD8(+)T cells is characterized by contracted populations homing to lymphoid organs. T cell memory inflation, as seen for example after CMV infection, is the maintenance of expanded, functional, tissue-associated effector memory cell pools. Such memory pools may also be induced after adenovirus vaccination, and we recently defined common transcriptional and phenotypic features of these populations in mice and humans. However, the rules that govern which epitopes drive memory inflation compared with classical memory are not fully defined, and thus it is not currently possible to direct this process. We used our adenoviral model of memory inflation to first investigate the role of the promoter and then the role of the epitope context in determining memory formation. Specifically, we tested the hypothesis that conventional memory could be converted to inflationary memory by simple presentation of the Ag in the form of minigene vectors. When epitopes from LacZ and murine CMV that normally induce classical memory responses were presented as minigenes, they induced clear memory inflation. These data demonstrate that, regardless of the transgene promoter, the polypeptide context of a CD8(+)T cell epitope may determine whether classical or inflating memory responses are induced. The ability to direct this process by the use of minigenes is relevant to the design of vaccines and understanding of immune responses to pathogens.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26944930      PMCID: PMC4822682          DOI: 10.4049/jimmunol.1502687

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  44 in total

1.  Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes.

Authors:  Sarah C Gilbert; Jörg Schneider; Carolyn M Hannan; Jiang Ting Hu; Magdalena Plebanski; Robert Sinden; Adrian V S Hill
Journal:  Vaccine       Date:  2002-01-15       Impact factor: 3.641

2.  Evaluation of promoter strength in mouse and rat primary hepatocytes using adenovirus vectors.

Authors:  Eri Arita; Masuo Kondoh; Katsuhiro Isoda; Hikaru Nishimori; Takeshi Yoshida; Hiroyuki Mizuguchi; Kiyohito Yagi
Journal:  Eur J Pharm Biopharm       Date:  2008-03-29       Impact factor: 5.571

3.  Evaluation of viral and mammalian promoters for use in gene delivery to salivary glands.

Authors:  Changyu Zheng; Bruce J Baum
Journal:  Mol Ther       Date:  2005-09       Impact factor: 11.454

4.  Four distinct patterns of memory CD8 T cell responses to chronic murine cytomegalovirus infection.

Authors:  Michael W Munks; Kathy S Cho; Amelia K Pinto; Sophie Sierro; Paul Klenerman; Ann B Hill
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

5.  Use of the human elongation factor 1 alpha promoter as a versatile and efficient expression system.

Authors:  D W Kim; T Uetsuki; Y Kaziro; N Yamaguchi; S Sugano
Journal:  Gene       Date:  1990-07-16       Impact factor: 3.688

6.  Evolution of diverse antiviral CD8+ T cell populations after murine cytomegalovirus infection.

Authors:  Sophie Sierro; Robert Rothkopf; Paul Klenerman
Journal:  Eur J Immunol       Date:  2005-04       Impact factor: 5.532

7.  Memory inflation: continuous accumulation of antiviral CD8+ T cells over time.

Authors:  Urs Karrer; Sophie Sierro; Markus Wagner; Annette Oxenius; Hartmut Hengel; Ulrich H Koszinowski; Rodney E Phillips; Paul Klenerman
Journal:  J Immunol       Date:  2003-02-15       Impact factor: 5.422

8.  Single-dose protection against Plasmodium berghei by a simian adenovirus vector using a human cytomegalovirus promoter containing intron A.

Authors:  S Sridhar; A Reyes-Sandoval; S J Draper; A C Moore; S C Gilbert; G P Gao; J M Wilson; A V S Hill
Journal:  J Virol       Date:  2008-02-06       Impact factor: 5.103

9.  A dominant role for the immunoproteasome in CD8+ T cell responses to murine cytomegalovirus.

Authors:  Sarah Hutchinson; Stuart Sims; Geraldine O'Hara; Jon Silk; Uzi Gileadi; Vincenzo Cerundolo; Paul Klenerman
Journal:  PLoS One       Date:  2011-02-03       Impact factor: 3.240

10.  Non-hematopoietic cells in lymph nodes drive memory CD8 T cell inflation during murine cytomegalovirus infection.

Authors:  Nicole Torti; Senta M Walton; Thomas Brocker; Thomas Rülicke; Annette Oxenius
Journal:  PLoS Pathog       Date:  2011-10-27       Impact factor: 6.823

View more
  12 in total

Review 1.  Intratumoral infection by CMV may change the tumor environment by directly interacting with tumor-associated macrophages to promote cancer immunity.

Authors:  Dan A Erkes; Nicole A Wilski; Christopher M Snyder
Journal:  Hum Vaccin Immunother       Date:  2017-06-12       Impact factor: 3.452

Review 2.  Vaccine vectors: the bright side of cytomegalovirus.

Authors:  Andrea C Méndez; Cristina Rodríguez-Rojas; Margarita Del Val
Journal:  Med Microbiol Immunol       Date:  2019-03-21       Impact factor: 3.402

3.  Peptide Processing Is Critical for T-Cell Memory Inflation and May Be Optimized to Improve Immune Protection by CMV-Based Vaccine Vectors.

Authors:  Iryna Dekhtiarenko; Robert B Ratts; Renata Blatnik; Lian N Lee; Sonja Fischer; Lisa Borkner; Jennifer D Oduro; Thomas F Marandu; Stephanie Hoppe; Zsolt Ruzsics; Julia K Sonnemann; Mandana Mansouri; Christine Meyer; Niels A W Lemmermann; Rafaela Holtappels; Ramon Arens; Paul Klenerman; Klaus Früh; Matthias J Reddehase; Angelika B Riemer; Luka Cicin-Sain
Journal:  PLoS Pathog       Date:  2016-12-15       Impact factor: 6.823

4.  Adenoviral vaccine induction of CD8+ T cell memory inflation: Impact of co-infection and infection order.

Authors:  Lian N Lee; Beatrice Bolinger; Zoltan Banki; Catherine de Lara; Andrew J Highton; Julia M Colston; Claire Hutchings; Paul Klenerman
Journal:  PLoS Pathog       Date:  2017-12-27       Impact factor: 6.823

5.  Identification of a Novel CD8 T Cell Epitope Derived from Plasmodium berghei Protective Liver-Stage Antigen.

Authors:  Alexander Pichugin; Stasya Zarling; Leah Perazzo; Patrick Emmet Duffy; Hidde Lolke Ploegh; Urszula Krzych
Journal:  Front Immunol       Date:  2018-01-29       Impact factor: 7.561

Review 6.  Features of Effective T Cell-Inducing Vaccines against Chronic Viral Infections.

Authors:  Eleni Panagioti; Paul Klenerman; Lian N Lee; Sjoerd H van der Burg; Ramon Arens
Journal:  Front Immunol       Date:  2018-02-16       Impact factor: 7.561

Review 7.  The (gradual) rise of memory inflation.

Authors:  Paul Klenerman
Journal:  Immunol Rev       Date:  2018-05       Impact factor: 12.988

Review 8.  Novel viral vectors in infectious diseases.

Authors:  Ian R Humphreys; Sarah Sebastian
Journal:  Immunology       Date:  2017-09-26       Impact factor: 7.397

9.  Vaccination with recombinant adenovirus expressing peste des petits ruminants virus-F or -H proteins elicits T cell responses to epitopes that arises during PPRV infection.

Authors:  José Manuel Rojas; Miguel Avia; Elena Pascual; Noemí Sevilla; Verónica Martín
Journal:  Vet Res       Date:  2017-11-21       Impact factor: 3.683

10.  Divergent memory responses driven by adenoviral vectors are impacted by epitope competition.

Authors:  Julia M Colston; Claire Hutchings; Senthil Chinnakannan; Andrew Highton; Christian Perez-Shibayama; Burkhard Ludewig; Paul Klenerman
Journal:  Eur J Immunol       Date:  2019-05-29       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.